Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

AGA honors outstanding high school students with 2011 research fellowship awards

The American Gastroenterological Association (AGA) Research Foundation has announced the 2011 Student Research Fellowship Award recipients. Funded by The Eli and Edythe Broad Foundation, the awards are intended to stimulate interest in research careers in digestive diseases.

10 Jun 2011

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune diseases and cancer, today announced topline results from its randomised, double-blind, placebo-controlled Phase IIb clinical trial COMPONENT in RA.

8 Jun 2011

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative colitis.

7 Jun 2011

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.

3 Jun 2011

Shield raises EUR8.2M through Series A financing

Shield Therapeutics, the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has successfully raised EUR8.2m from Inventages Venture Capital (Inventages) in its first institutional financing round.

1 Jun 2011

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.

30 May 2011

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

4SC AG, a discovery and development company of targeted small molecule drugs for autoimmune and cancer diseases, will present pre-clinical data on vidofludimus - its lead small-molecule drug candidate against autoimmune diseases - in systemic lupus erythematosus at EULAR 2011, Europe's largest scientific conference on rheumatic diseases, in London, UK, from May 25-28, 2011.

27 May 2011

Scientists discover new mechanism that controls inflammation

The molecular machines that defend our body against infection don't huff and puff, but some of them apparently operate on the same principle as a steam engine.

26 May 2011

Leukemia protein plays a role in Alzheimer's disease

After decades of studying the pathological process that wipes out large volumes of memory, scientists at The Feinstein Institute for Medical Research discovered a molecule called c-Abl that has a known role in leukemia also has a hand in Alzheimer's disease.

25 May 2011

Research could pave way toward new anti-bacterial treatments

A group of proteins that act as the body's built-in line of defense against invading bacteria use a molecular trick to induce bacteria to destroy themselves, researchers at the Indiana University School of Medicine have determined. The research could point the way toward new anti-bacterial treatments that could take on bacteria that are resistant to antibiotics.

24 May 2011

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Naltrexone reduced inflammation in Crohn's patients in a research study at Penn State College of Medicine.

20 May 2011

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Researchers from Boston University School of Medicine, along with clinicians from Boston Medical Center, have found gastroenterologist knowledge of the appropriate immunizations to recommend to the inflammatory bowel disease patient is limited.

17 May 2011

Obese patients undergoing colon surgery more likely to develop costly surgical-site infections

Obese patients undergoing colon surgery are 60 percent more likely to develop dangerous and costly surgical-site infections than their normal-weight counterparts, new Johns Hopkins research suggests.

17 May 2011

GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

The University of Manchester, GlaxoSmithKline and AstraZeneca announce today the creation of the Manchester Collaborative Centre for Inflammation Research, a unique collaboration to establish a world-leading translational centre for inflammatory diseases. The project starts out with an initial investment of -5M from each partner over a three year period.

From The University of Manchester 12 May 2011

Insight into probiotic bacteria can help improve intestinal disease treatments

The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.

11 May 2011

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

AGA honors outstanding high school students with 2011 research fellowship awards

Topline results from 4SC vidofludimus Phase IIb trial against rheumatoid arthritis

Shire Canada receives expanded indication for MEZAVANT for treatment of ulcerative colitis

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

Shield raises EUR8.2M through Series A financing

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

Scientists discover new mechanism that controls inflammation

Leukemia protein plays a role in Alzheimer's disease

Research could pave way toward new anti-bacterial treatments

Naltrexone improves clinical, inflammatory activity in Crohn's disease patients

Gastroenterologists have limited knowledge of appropriate immunizations for IBD patients, study finds

Obese patients undergoing colon surgery more likely to develop costly surgical-site infections

GSK, AstraZeneca and University of Manchester create new collaborative centre for inflammation research

Insight into probiotic bacteria can help improve intestinal disease treatments

AGA's cutting-edge research on GI disorders to be presented at DDW 2011

FibroGen announces proof-of-principle for FG-4592 Phase 2 study in hemodialysis patients

Santarus' budesonide MMX Phase III data in ulcerative colitis to be presented at DDW 2011

Scientists discover how immune cells recognize invading pathogens in the body

Antibiotics may serve as effective treatment for appendicitis than surgery

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Inflammatory Bowel Disease News and Research

Latest Inflammatory Bowel Disease News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in